These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 33887821

  • 1. Clinical Characteristics and Treatment Outcomes of Childhood Acute Promyelocytic Leukemia in Korea: A Nationwide Multicenter Retrospective Study by Korean Pediatric Oncology Study Group.
    Park KM, Yoo KH, Kim SK, Lee JW, Chung NG, Ju HY, Koo HH, Lyu CJ, Han SM, Han JW, Choi JY, Hong KT, Kang HJ, Shin HY, Im HJ, Koh KN, Kim H, Kook H, Baek HJ, Kim BR, Yang EJ, Lim JY, Park ES, Choi EJ, Park SK, Lee JM, Shim YJ, Kim JY, Park JK, Kong SG, Choi YB, Cho B, Lim YT.
    Cancer Res Treat; 2022 Jan; 54(1):269-276. PubMed ID: 33887821
    [Abstract] [Full Text] [Related]

  • 2. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
    De Botton S, Dombret H, Sanz M, Miguel JS, Caillot D, Zittoun R, Gardembas M, Stamatoulas A, Condé E, Guerci A, Gardin C, Geiser K, Makhoul DC, Reman O, de la Serna J, Lefrere F, Chomienne C, Chastang C, Degos L, Fenaux P.
    Blood; 1998 Oct 15; 92(8):2712-8. PubMed ID: 9763554
    [Abstract] [Full Text] [Related]

  • 3. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group.
    Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L.
    Blood; 1999 Aug 15; 94(4):1192-200. PubMed ID: 10438706
    [Abstract] [Full Text] [Related]

  • 4. Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience.
    Cheng Y, Zhang L, Wu J, Lu A, Wang B, Liu G.
    Eur J Haematol; 2013 Dec 15; 91(6):483-9. PubMed ID: 24033687
    [Abstract] [Full Text] [Related]

  • 5. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb 15; 9(1):28-33. PubMed ID: 17306073
    [Abstract] [Full Text] [Related]

  • 6. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.
    Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Woods WG, Ogden A, Weinstein H, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH.
    Blood; 2002 Dec 15; 100(13):4298-302. PubMed ID: 12393590
    [Abstract] [Full Text] [Related]

  • 7. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
    Ohno R, Ohnishi K, Takeshita A, Tanimoto M, Murakami H, Kanamaru A, Asou N, Kobayashi T, Kuriyama K, Ohmoto E.
    Leukemia; 1994 Dec 15; 8 Suppl 3():S64-9. PubMed ID: 7808028
    [Abstract] [Full Text] [Related]

  • 8. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
    Xin L, Wan-jun S, Zeng-jun L, Yao-zhong Z, Yun-tao L, Yan L, Chang-chun W, Qiao-chuan L, Ren-chi Y, Ming-zhe H, Jian-xiang W, Lu-gui Q.
    Leuk Res; 2007 Jun 15; 31(6):765-71. PubMed ID: 17007927
    [Abstract] [Full Text] [Related]

  • 9. Effect of arsenic trioxide on the treatment of children with newly diagnosed acute promyelocytic leukemia in China.
    Zhang L, Zhu X, Zou Y, Chen Y, Chen X.
    Int J Hematol; 2011 Feb 15; 93(2):199-205. PubMed ID: 21287409
    [Abstract] [Full Text] [Related]

  • 10. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.
    Bally C, Fadlallah J, Leverger G, Bertrand Y, Robert A, Baruchel A, Guerci A, Recher C, Raffoux E, Thomas X, Leblanc T, Idres N, Cassinat B, Vey N, Chomienne C, Dombret H, Sanz M, Fenaux P, Adès L.
    J Clin Oncol; 2012 May 10; 30(14):1641-6. PubMed ID: 22473162
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 May 10; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 14. Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).
    Asou N, Adachi K, Tamura U, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama U, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake H, Ohno R.
    Cancer Chemother Pharmacol; 2001 Aug 10; 48 Suppl 1():S65-71. PubMed ID: 11587370
    [Abstract] [Full Text] [Related]

  • 15. Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials.
    Micol JB, Raffoux E, Boissel N, Lengliné E, Canet E, Daniel MT, Labarthe Ad, Maarek O, Cassinat B, Adès L, Baruchel A, Degos L, Azoulay E, Dombret H.
    Eur J Cancer; 2014 Apr 10; 50(6):1159-68. PubMed ID: 24440088
    [Abstract] [Full Text] [Related]

  • 16. Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG.
    Kungwankiattichai S, Owattanapanich W, Rattanathammethee T, Rattarittamrong E, Chanswangphuwana C, Polprasert C, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Prayongratana K, Sriswasdi C, Nakhakes C.
    Hematology; 2023 Dec 10; 28(1):2191462. PubMed ID: 36951362
    [Abstract] [Full Text] [Related]

  • 17. Oral arsenic trioxide, all-trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long-term results and unique prognostic indicators.
    Gill HS, Yim R, Kumana CR, Tse E, Kwong YL.
    Cancer; 2020 Jul 15; 126(14):3244-3254. PubMed ID: 32365228
    [Abstract] [Full Text] [Related]

  • 18. Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study.
    Jastaniah W, Alsultan A, Al Daama S, Ballourah W, Bayoumy M, Al-Anzi F, Al Shareef O, Abrar MB, Al Sudairy R, Al Ghemlas I.
    Hematology; 2018 Jul 15; 23(6):316-323. PubMed ID: 29212418
    [Abstract] [Full Text] [Related]

  • 19. Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia.
    Iland H, Bradstock K, Seymour J, Hertzberg M, Grigg A, Taylor K, Catalano J, Cannell P, Horvath N, Deveridge S, Browett P, Brighton T, Chong L, Springall F, Ayling J, Catalano A, Supple S, Collins M, Di Iulio J, Reynolds J, Australasian Leukaemia and Lymphoma Group.
    Haematologica; 2012 Feb 15; 97(2):227-34. PubMed ID: 21993673
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.